Lonza Group Ag Total Long Term Liabilities 2012-2023 | LZAGY
- Lonza Group Ag total long term liabilities for the quarter ending December 31, 2023 were $5.094B, a 1.52% decline year-over-year.
- Lonza Group Ag total long term liabilities for 2022 were $3.784B, a 18.93% decline from 2021.
- Lonza Group Ag total long term liabilities for 2021 were $4.667B, a 1.62% decline from 2020.
- Lonza Group Ag total long term liabilities for 2020 were $4.744B, a 2.45% increase from 2019.
Lonza Group Ag Annual Total Long Term Liabilities (Millions of US $) |
|
---|---|
2022 | $3,784 |
2021 | $4,667 |
2020 | $4,744 |
2019 | $4,631 |
2017 | $5,451 |
2016 | $2,884 |
2015 | $2,640 |
2014 | $3,019 |
2013 | $3,515 |
2012 | $3,616 |
2011 | $4,205 |
Lonza Group Ag Quarterly Total Long Term Liabilities (Millions of US $) |
|
---|---|
2023-12-31 | $5,094 |
2022-12-31 | $3,784 |
2022-06-30 | $4,175 |
2021-12-31 | $4,667 |
2021-06-30 | $5,172 |
2020-12-31 | $4,744 |
2020-06-30 | $5,676 |
2019-12-31 | $4,631 |
2019-06-30 | $4,981 |
2018-12-31 | $5,364 |
2018-06-30 | $5,034 |
2017-12-31 | $5,451 |
2017-06-30 | $2,703 |
2016-12-31 | $2,884 |
2016-06-30 | $3,034 |
2015-12-31 | $2,640 |
2015-06-30 | $2,277 |
2014-12-31 | $3,019 |
2014-06-30 | $3,871 |
2013-12-31 | $3,515 |
2013-06-30 | $3,985 |
2012-12-31 | $3,616 |
2012-06-30 | $3,153 |
2011-12-31 | $4,205 |
2011-06-30 | $1,414 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $45.423B | $7.478B |
Lonza Group AG operates as a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The company's Life Science Ingredients segment produces nutrition ingredients for applications in nutrition (food, feed and pharmaceutical application) and chemical intermediates for the agricultural industry. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics. Lonza Group AG is headquartered in Basel, Switzerland. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $202.220B | 25.79 |
Stryker (SYK) | United States | $143.322B | 32.30 |
Boston Scientific (BSX) | United States | $130.065B | 37.39 |
Medtronic (MDT) | Ireland | $112.498B | 16.74 |
EssilorLuxottica (ESLOY) | France | $111.686B | 0.00 |
Haleon (HLN) | United Kingdom | $43.501B | 28.26 |
GE HealthCare Technologies (GEHC) | United States | $39.264B | 20.36 |
ResMed (RMD) | United States | $37.048B | 30.44 |
Terumo (TRUMY) | Japan | $29.575B | 41.77 |
Koninklijke Philips (PHG) | Netherlands | $25.012B | 19.14 |
Zimmer Biomet Holdings (ZBH) | United States | $21.536B | 13.71 |
Insulet (PODD) | United States | $18.791B | 74.86 |
Baxter (BAX) | United States | $17.673B | 11.51 |
Smith & Nephew SNATS (SNN) | United Kingdom | $10.619B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $10.338B | 35.13 |
BellRing Brands (BRBR) | United States | $9.136B | 38.63 |
Demant (WILYY) | Denmark | $8.351B | 0.00 |
Lantheus Holdings (LNTH) | United States | $6.084B | 14.14 |
Haemonetics (HAE) | United States | $4.474B | 21.43 |
TG Therapeutics (TGTX) | United States | $4.460B | 0.00 |
ICU Medical (ICUI) | United States | $4.318B | 41.21 |
Prestige Consumer Healthcare (PBH) | United States | $3.983B | 19.75 |
Perrigo (PRGO) | Ireland | $3.596B | 10.59 |
Neogen (NEOG) | United States | $3.517B | 40.57 |
Envista Holdings (NVST) | United States | $3.509B | 26.14 |
Agios Pharmaceuticals (AGIO) | United States | $3.368B | 0.00 |
GN Store Nord (GNNDY) | Denmark | $3.041B | 19.50 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
QuidelOrtho (QDEL) | United States | $2.942B | 18.94 |
LeMaitre Vascular (LMAT) | United States | $2.342B | 56.97 |
Warby Parker (WRBY) | United States | $1.964B | 0.00 |
Green Thumb Industries (GTBIF) | United States | $1.888B | 33.04 |
AtriCure (ATRC) | United States | $1.826B | 0.00 |
InMode (INMD) | Israel | $1.630B | 9.80 |
Curaleaf Holdings (CURLF) | Canada | $1.384B | 0.00 |
AdaptHealth (AHCO) | United States | $1.357B | 9.70 |
Maravai LifeSciences Holdings (MRVI) | United States | $1.280B | 0.00 |
BioLife Solutions (BLFS) | United States | $1.206B | 0.00 |
Owens & Minor (OMI) | United States | $0.995B | 7.77 |
Phibro Animal Health (PAHC) | United States | $0.966B | 17.04 |
CeriBell (CBLL) | United States | $0.962B | 0.00 |
National Vision Holdings (EYE) | United States | $0.906B | 30.29 |
Capricor Therapeutics (CAPR) | United States | $0.895B | 0.00 |
Evolus (EOLS) | United States | $0.866B | 0.00 |
Verano Holdings (VRNOF) | United States | $0.691B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.605B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.582B | 17.56 |
Quanterix (QTRX) | United States | $0.580B | 0.00 |
Surmodics (SRDX) | United States | $0.549B | 0.00 |
Valneva SE (VALN) | France | $0.426B | 0.00 |
Canopy Growth (CGC) | Canada | $0.398B | 0.00 |
ZimVie (ZIMV) | United States | $0.393B | 33.12 |
Viemed Healthcare (VMD) | United States | $0.353B | 33.59 |
Cerus (CERS) | United States | $0.331B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.320B | 21.45 |
Sanara MedTech (SMTI) | United States | $0.308B | 0.00 |
Biote (BTMD) | United States | $0.301B | 13.90 |
Zynex (ZYXI) | United States | $0.287B | 60.07 |
Jin Medical (ZJYL) | China | $0.284B | 0.00 |
MacroGenics (MGNX) | United States | $0.273B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.269B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.264B | 0.00 |
Omeros (OMER) | United States | $0.256B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.236B | 15.90 |
High Tide (HITI) | Canada | $0.221B | 91.67 |
Brainsway (BWAY) | Israel | $0.181B | 217.20 |
Organigram Holdings (OGI) | Canada | $0.172B | 0.00 |
FitLife Brands (FTLF) | United States | $0.151B | 20.39 |
Rockwell Medical (RMTI) | United States | $0.137B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.129B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.116B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.111B | 0.00 |
Veru (VERU) | United States | $0.107B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.104B | 0.00 |
Fonar (FONR) | United States | $0.095B | 9.82 |
Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 23.10 |
Cellectar Biosciences (CLRB) | United States | $0.086B | 0.00 |
Sanuwave Health (SNWVD) | United States | $0.079B | 2.67 |
Modular Medical (MODD) | United States | $0.072B | 0.00 |
InterCure (INCR) | Israel | $0.070B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.070B | 0.00 |
MariMed (MRMD) | United States | $0.062B | 0.00 |
Safety Shot (SHOT) | United States | $0.062B | 0.00 |
Apyx Medical (APYX) | United States | $0.053B | 0.00 |
Exagen (XGN) | United States | $0.050B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.048B | 0.00 |
Cytosorbents (CTSO) | United States | $0.040B | 0.00 |
ImmuCell (ICCC) | United States | $0.028B | 0.00 |
Flora Growth (FLGC) | United States | $0.017B | 0.00 |
Nephros (NEPH) | United States | $0.017B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.012B | 0.00 |
GlucoTrack (GCTK) | United States | $0.008B | 0.00 |
NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
Agape ATP (ATPC) | $0.006B | 0.00 | |
Sharps Technology (STSS) | United States | $0.005B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
Senestech (SNES) | United States | $0.001B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
United-Guardian (UG) | United States | $0.000B | 14.20 |
SNDL (SNDL) | Canada | $0.000B | 0.00 |